Affiliation:
1. Department of Cardiothoracic Surgery, Cangzhou Central Hospital,
Cangzhou, China
2. Nursing Department, Cangzhou Central Hospital, Cangzhou,
China
Abstract
AbstractGeriatric nutritional risk index (GNRI), a newly developed indicator of
nutritional status retrieved by serum albumin concentration and ideal body
weight, has been suggested as a prognostic factor for various malignancies. The
aim of the study was to summarize the prognostic role of GNRI for patients with
non-small cell lung cancer (NSCLC) in a meta-analysis. Cohort studies evaluating
the relationship between GNRI at baseline and survival OF NSCLC were retrieved
by search of PubMed, Embase, and Web of Science databases from inception to
January 12, 2022. A conservative random-effect model incorporating the possible
influence of between-study heterogeneity was used to pool the results. Eleven
cohorts including 2865 patients with NSCLC were included. Compared to those with
higher GNRI, NSCLC patients with lower GNRI were associated with poorer overall
survival [OS, hazard ratio (HR): 2.39, 95% CI: 1.97–2.91,
p<0.001; I2=29%), progression-free survival (HR: 1.94,
95% CI: 1.52–2.47, p<0.001; I2=29%), and
cancer-specific survival (HR: 2.59, 95% CI: 1.55–4.35,
p<0.001; I2=0%). Subgroup analyses showed that the
significant association between lower GNRI and worse OS in patients with NSCLC
was not affected by study characteristics including study location, design,
cancer stage, treatment, or follow-up durations (p for subgroup effects
all<0.001). In conclusion, a lower GNRI in patients with NSCLC may be a
predictor of poor survival. Nutritional status indicated by GNRI may be
important for the prognostic prediction of patients with NSCLC.
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,General Medicine,Endocrinology, Diabetes and Metabolism
Reference53 articles.
1. Cancer statistics in China and United States, 2022: profiles, trends, and
determinants;C Xia;Chin Med J (Engl),2022
2. Cancer statistics, 2022;R L Siegel;CA Cancer J Clin,2022
3. NCCN guidelines insights: non-small cell lung cancer, version 2.2021;D S Ettinger;J Natl Compr Canc Netw,2021
4. Therapy for stage IV non-small-cell lung cancer with driver alterations: ASCO
and OH (CCO) joint guideline update;N H Hanna;J Clin Oncol,2021
5. Clinical value of nutritional status in cancer: what is its impact and how it
affects disease progression and prognosis?;M Mantzorou;Nutr Cancer,2017
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献